Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05079334 · ClinicalTrials.gov registry record
Family History and Cancer Risk Study
A clinical trial of Neoplastic Syndromes, Hereditary and Comparative Effectiveness Research, sponsored by Vanderbilt University Medical Center.
- Active
- Registry status
- 1,847
- Enrollment target
- 2
- Study locations
NCT05079334: Active study of Neoplastic Syndromes, Hereditary and Comparative Effectiveness Research, sponsored by Vanderbilt University Medical Center.
NCT05079334 is a study of Neoplastic Syndromes, Hereditary and Comparative Effectiveness Research that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 1,847 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05079334, a study of Neoplastic Syndromes, Hereditary and Comparative Effectiveness Research, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 1,847 participants
- Enrollment target
- 2
- Study locations
Study Summary
Investigators from Vanderbilt University Medical Center (VUMC), Duke University, and Meharry Medical College (MMC) are collaborating on a family health history study to deploy a family health history (FHH) platform, MeTree. Recruited participants will complete surveys, the MeTree questionnaire, and MeTree will determine the participant's cancer risk based on current guidelines. The study team will offer genetic counseling to high-risk participants. Investigators will track participant outcomes and behaviors from the use of MeTree to determine the efficiency of the use of MeTree compared to completion of pedigrees in clinic.
Primary Outcome
Proportion of participants sent a MeTree link who complete the MeTree family health history questionnaire, defined by generation of a MeTree risk report. Engagement steps (link clicked, account created) will be summarized descriptively. 95% confidence intervals will be reported using the Wilson method; subgroup comparisons by site and demographics will be exploratory.
Conditions Studied
Study Locations (2)
Tennessee
- Meharry Medical College - Nashville
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,847 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2026-06 |
What the registry record for NCT05079334 still lists
NCT05079334 is an observational study that tracks outcomes without assigning an intervention. Its 1,847 participants enrollment target places it among the larger protocols in the corpus.
The record links to 2 conditions, with Neoplastic Syndromes, Hereditary appearing as the primary indexed condition, and to 0 interventions.
NCT05079334 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT05079334 about?
NCT05079334 is a clinical study titled "Family History and Cancer Risk Study". Investigators from Vanderbilt University Medical Center (VUMC), Duke University, and Meharry Medical College (MMC) are collaborating on a family health history study to deploy a family health history (FHH) platform, MeTree. Recruited participants will complete surveys, the MeTree questionnaire, and ...
What is the current status of trial NCT05079334?
This trial is currently active not recruiting. The enrollment target is 1,847 participants. The study started on 2022-01-01. Estimated completion is 2026-06.
What conditions does trial NCT05079334 study?
This clinical trial studies the following conditions: Neoplastic Syndromes, Hereditary, Comparative Effectiveness Research.
Who is sponsoring clinical trial NCT05079334?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05079334 being conducted?
This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06465810 · 1,850 participants
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- NCT06580080 · 1,850 participants · NA
Evaluation of Are You Ready?
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
- NCT07104240 · 1,836 participants · NA
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI